Skip to content

All our lab's publications is available on PubMed.

Papers

2023

  • S. Maseko, Y. Brammerloo, I. Van Molle, A. Sogues, C. Martin, C. Gorgulla, E. Plant, J. Olivet, J. Blavier, T. Ntombela, F. Delvigne, H. Arthanari, H. El Hajj, A. Bazarbachi, C Van Lint, K. Salehi-Ashtiani, H. Remaut, S. Ballet, A. Volkov and J-C. Twizere. (2023) "Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction" Antiviral Research, 217

  • E. Plant, M Bellefroid and C. Van Lint. (2023) "A complex network of transcription factors and epigenetic regulators involved in bovine leukemia virus transcriptional regulation" Retrovirology, 20

  • D. Chatterjee, Y. Zhang, C. Ngassaki-Yoka, A. Dutilleul, S. Khalfi, O. Hernalsteens, T. Wiche Salinas, J. Dias, H. Chen, Y. Smail, J-P. Goulet, B. Bell, J-P. Routy, C. Van Lint and P. Ancuta. (2023) "Identification of aryl hydrocarbon receptor as a barrier to HIV-1 infection and outgrowth in CD4+ T cells" Cell Reports, 42

2022

  • S. Pasquereau, M. Galais, M. Bellefroid, I. Angona, S. Morot-Bizot, L. Ismaili, C. Van Lint and G. Herbein (2022). "Ferulic derivatives block coronaviruses HCoV229E and SARS-CoV-2 replication in vitro" Scientific reports, 12

  • M. Bellefroid, A. Rodari, M. Galais, P. Krijger, S. Tjalsma, L. Nestola, E. PLant, E. Vos, S. Cristinelli, B. Van Driessche, C. Vanhulle, A. Ait-Ammar, A. Burny, A. Ciuffi, W. de Laat and C. Van Lint (2022). "Role of the cellular factor CTCF in the regulation of bovine leukemia virus latency and three-dimensional chromatin organization" Nucleic Acids Research, Volume 50, Issue 6.

  • Verdikt, R., Bendoumou, M., Bouchat, S., Nestola, L., Pasternak, A. O., Darcis, G., Avettand-Fenoel, V., Vanhulle, C., Ait-Ammar, A., Santangelo, M., Plant, E., Douce, V. L., Delacourt, N., Cicilionyte, A., Necsoi, C., Corazza, F., Passaes, C. P. B., Schwartz, C., Bizet, M., Fuks, F., Sáez-Cirión, A., Rouzioux, C., De Wit, S., Berkhout, B., Gautier, V., Rohr, O., & Van Lint, C. (2022). "Novel role of UHRF1 in the epigenetic repression of the latent HIV-1." EBioMedicine, 79, 103985.

2021

  • Rodari, A., Darcis, G., & Van Lint, C. (2021). "The Current Status of Latency Reversing Agents for HIV-1 Remission." Annual review of virology, 8(1), 491-514.

  • Kula-Pacurar, A., Rodari, A., Darcis, G., & Van Lint, C. (2021). "Shocking HIV-1 with immunomodulatory latency reversing agents." Seminars in immunology., 101478. .

  • Hamann, M. M., Ehmele, P., Verdikt, R., Bialek-Waldmann, J. J., Virdi, S., Günther, T., Van Lint, C., Grundhoff, A., Hauber, J., & Lange, U. C. (2021). "Transcriptional behavior of the HIV-1 promoter in context of the BACH2 prominent proviral integration gene." Virus research, 293, 198260.

  • Verdikt, R., Hernalsteens, O., & Van Lint, C. (2021). "Epigenetic mechanisms of hiv-1 persistence." Vaccines, 9(5), 514.

  • Ait-Ammar, A., Bellefroid, M., Daouad, F., Martinelli, V., Van Assche, J., Wallet, C., Rodari, A., De Rovere, M., Fahrenkrog, B., Schwartz, C., Van Lint, C., Gautier, V., & Rohr, O. (2021).(C. Van Lint, V. Gautier and O. Rohr are co-last authors) "Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage." Scientific reports, 11(1), 2692.

2020

  • Dutilleul, A., Rodari, A., & Van Lint, C. (2020). "Depicting HIV-1 Transcriptional Mechanisms: A Summary of What We Know." Viruses, 12(12). .

  • Ait-Ammar, A., Kula, A., Darcis, G., Verdikt, R., De Wit, S., Gautier, V., Mallon, P., Marcello, A., Rohr, O., & Van Lint, C. (2020). "Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs." Frontiers in microbiology, 10, 3060. .

  • Lange, U. C., Verdikt, R., Ait-Ammar, A., & Van Lint, C. (2020). "Epigenetic crosstalk in chronic infection with HIV-1." Seminars in Immunopathology. .

  • Darcis, G., Kootstra, N., Hooibrink, B., Van Montfort, T., Maurer, I., Groen, K., Jurriaans, S., Bakker, M., Van Lint, C., Berkhout, B., & Pasternak, A. (2020). "CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency." Cell reports, 30(7), 2284-2296.e3. .

2019

  • Forouzanfar, F., Ali, S., Wallet, C., De Rovere, M., Ducloy, C., El Mekdad, H., El Maassarani, M., Aït-Ammar, A., Van Assche, J., Boutant, E., Daouad, F., Margottin-Goguet, F., Moog, C., Van Lint, C., Schwartz, C., & Rohr, O. (2019). "HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing." Scientific reports, 9(1), 13154. .

  • Wallet, C., De Rovere, M., Van Assche, J., Daouad, F., De Wit, S., Gautier, V. V., Mallon, P. P., Marcello, A., Van Lint, C., Rohr, O., & Schwartz, C. (2019). "Microglial Cells: The Main HIV-1 Reservoir in the Brain." Frontiers in Cellular and Infection Microbiology, 9, 362. .

  • Verdikt, R., Darcis, G., Aït-Ammar, A., & Van Lint, C. (2019). "Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistence." Current opinion in virology, 38, 63-69. .

  • Malu, A., Hutchison, T., Yapindi, L., Smith, K., Nelson, K., Bergeson, R., Pope, J., Romeo, M., Harrod, C. K., Ratner, L., Van Lint, C., & Harrod, R. (2019). "The human T-cell leukemia virus type-1 tax oncoprotein dissociates NF-kB p65RelA-Stathmin complexes and causes catastrophic mitotic spindle damage and genomic instability." Virology, 535, 83-101. .

  • Turrini, F., Saliu, F., Forlani, G., Das, A. A., Van Lint, C., Accolla, R. R., Berkhout, B., Poli, G., & Vicenzi, E. (2019). "Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines." Virus research, 269, 197631. .

  • Bouchat, S., & Van Lint, C. (2019). "[Viral latency of HIV-1]." Virologie, 23(4), 195-210. .

  • Kula, A., Delacourt, N., Bouchat, S., Darcis, G., Avettand-Fenoel, V., Verdikt, R., Corazza, F., Necsoi, C. V., Vanhulle, C., Bendoumou, M., Burny, A., De Wit, S., Rouzioux, C., Rohr, O., & Van Lint, C. (2019). "Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments." Journal of acquired immune deficiency syndromes, 80(5), 605-613. .

2018

  • Van Lint, C. (2018). "Stop HUSHing on SIV/HIV." Nature Microbiology, 3(12), 1336-1338. .

  • Sarracino, A., Gharu, L., Kula, A., Pasternak, A., Avettand-Fenoel, V., Rouzioux, C., Bardina, M., De Wit, S., Benkirane, M., Berkhout, B., Van Lint, C., & Marcello, A. (2018). "Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3." MBio, 9(6). .

  • Collignon, E., Canale, A., Al Wardi, C., Bizet, M., Calonne, E., Dedeurwaerder, S., Garaud, S., Naveaux, C., Barham, W., Wilson, A., Bouchat, S., Hubert, P., Van Lint, C., Yull, F., Sotiriou, C., Willard-Gallo, K., Noël, A., & Fuks, F. (2018). "Immunity drives TET1 regulation in cancer through NF-kB." Science advances, 4(6), eaap7309. .

  • El Khoury, G., Darcis, G., Lee,, Bouchat, S., Van Driessche, B., Purcell, D., & Van Lint, C. (2018). "The Molecular Biology of HIV Latency." Advances in experimental medicine and biology, 1075, 187-212. .

2017

  • Darcis, G., Van Driessche, B., Bouchat, S., Kirchhoff, F., & Van Lint, C. (2017). "Molecular Control of HIV and SIV Latency." Current topics in microbiology and immunology. .

  • Fauquenoy, S., Robette, G., Kula, A., Vanhulle, C., Bouchat, S., Delacourt, N., Rodari, A., Marban, C., Schwartz, C., Burny, A., Rohr, O., Van Driessche, B., & Van Lint, C. (2017). "Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites." Scientific reports, 7, 43221. .

  • Darcis, G., Bouchat, S., Kula, A., Van Driessche, B., Delacourt, N., Vanhulle, C., Avettand-Fenoel, V., De Wit, S., Rohr, O., Rouzioux, C., & Van Lint, C. (2017). "Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir." AIDS, 31(2), 181-189. .

  • Hotter, D., Krabbe, T., Reith, E., Gawanbacht, A., Rahm, N., Ayouba, A., Van Lint, C., Peeters, M., & Kirchhoff, F. (2017). "Primate lentiviruses use at least three alternative strategies to suppress NF-#B-mediated immune activation." P L o S Pathogens, 13(8),e1006598.

  • Darcis, G., Van Driessche, B., & Van Lint, C. (2017). "HIV latency: should we shock or lock?" Trends in immunology,38(3), 217–228. .

  • Gama, L., Pianowski, L. F., Haase, A., Van Lint, C., Siliciano, R., Abreu, C. M., Shirk, E., Price, S. S., Li, M., Laird, G. G., Pate, K. A. M., Wietgrefe, S., & O'connor, S. (2017). "Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques." AIDS, 31(1), 5-14 .

  • Passaes, C. P. B., Bruel, T., Decalf, J., David, A., Angin, M., Monceaux, V., Muller-Trutwin, M., Noel, N., Bourdic, K., Lambotte, O., Albert, M., Duffy, D., Schwartz, O., Sáez-Cirión, A., ANRS RHIVIERA, C., Barré-Sinoussi, F., Rouzioux, C., Autran, B., Benkirane, M., Guedj, J., Hocqueloux, L., Katlama, C., Legrand, R., Meyer, L., Mouquet, H., Taburet,A. M., Van Lint, C., & Delfraissy, J. (2017). "Ultrasensitive HIV-1 p24 assay detects single infected cells and differences in reservoir induction by latency reversal agents." Journal of virology, 91(6), e02296-16. .

  • Schwartz, C., Bouchat, S., Marban, C., Gautier, V., Van Lint, C., Rohr, O., & Le Douce, V. (2017). "On the way to find a cure: Purging latent HIV-1 reservoirs." Biochemical pharmacology, 146, 10-22..

2016

  • Le Douce, V., Forouzanfard, F., Eilebrecht, S., Van Driessche, B., Ait-Ammar, A., Verdikt, R., Kurashige, Y., Marban, C., Gautier, V., Candolfi, E., Benecke, A., Van Lint, C., Rohr, O., & Schwartz, C. (2016).(C. Van Lint, O. Rohr and C. Schwartz are co-last authors) "HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1." Scientific Reports, 6, 34920 .

  • Bouchat, S., Delacourt, N., Kula, A., Darcis, G., Van Driessche, B., Corazza, F., Gatot, J.-S., Melard, A., Vanhulle, C., Kabeya, K., Pardons, M., Avettand-Fenoel, V., Clumeck, N., De Wit, S., Rohr, O., Rouzioux, C., & Van Lint, C. (2016). "Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1." EMBO molecular medicine, 8(2), 117-138. .

  • Van Driessche, B., Rodari, A., Delacourt, N., Fauquenoy, S., Vanhulle, C., Burny, A., Rohr, O., & Van Lint, C. (2016). "Characterization of new RNA polymerase III and RNA polymerase II transcriptional promoters in the Bovine Leukemia Virus genome." Scientific report, 6, 31125. .

  • Noel, N., Peña, R., David, A., Avettand-Fenoel, V., Erkizia, I., Jimenez, E., Lecuroux, C., Rouzioux, C., Boufassa, F., Pancino, G., Venet, A., Van Lint, C., Martinez-Picado, J., Lambotte, O., Sáez-Cirión, A., & Prado, J. G. (2016). "Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation." Journal of virology, 90(13), 6148-6158..

  • Darcis, G., Van Driessche, B., & Van Lint, C. (2016). "Preclinical shock strategies to reactivate latent HIV-1: an update." Current opinion in HIV and AIDS, 11(4), 388-393..

  • Kumar, A. A., Abbas, W., Colin, L., Khan, K. A., Bouchat, S., Varin, A., Larbi, A., Gatot, J.-S., Kabeya, K., Vanhulle, C., Delacourt, N., Pasquereau, S., Coquard, L., Borch, A., König, R., Clumeck, N., De Wit, S., Rohr, O., Rouzioux, C., Fulöp, T., Van Lint, C., & Herbein, G. (2016). "Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line. Scientific reports, 6, 24090. .

  • Kumar, A. A., Abbas, W., Bouchat, S., Gatot, J.-S., Pasquereau, S., Kabeya, K., Clumeck, N., De Wit, S., Van Lint, C., & Herbein, G. (2016). "Limited HIV-1 Reactivation in Resting CD4 + T cells from Aviremic Patients under Protease Inhibitors." Scientific reports, 6, 38313..

  • Darcis, G., Coombs, R. R., & Van Lint, C. (2016). "Exploring the anatomical HIV reservoirs: Role of the testicular tissue." AIDS, 30(18), 2891-2893..

2015

  • Kumar, A. A., Darcis, G., Van Lint, C., & Herbein, G. (2015). "Epigenetic control of HIV-1 post integration latency: implications for therapy." Clinical Epigenetics, 7(1), 103..

  • Turrini, F., Marelli, S., Kajaste-Rudnitski, A., Lusic, M., Van Lint, C., Das, A. T., Harwig, A., Berkhout, B., & Vicenzi, E. (2015). "HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter." Retrovirology, 12(1), 104..

  • Thelie, A., Desiderio, S., Hanotel, J., Quigley, I., Van Driessche, B., Rodari, A., Borromeo, M., Kricha, S., Lahaye, F., Croce, J., Cerda-Moya, G., Ordono-Fernandez, J., Bolle, B., Lewis, K., Sander, M., Pierani, A., Schubert, M., Johnson, J., Kintner, C., Pieler, T., Van Lint, C., Henningfeld, K. A., Bellefroid, E., & Van Campenhout, C. (2015). "Prdm12 specifies V1 interneurons through cross-repressive interactions with Dbx1 and Nkx6 genes in Xenopus." Development, 142(19), 3416-3428..

  • Darcis, G., Kula, A., Bouchat, S., Fujinaga, K., Corazza, F., Ait-Ammar, A., Delacourt, N., Melard, A., Kabeya, K., Vanhulle, C., Van Driessche, B., Gatot, J.-S., Cherrier, T., Pianowski, L. F., Gama, L., Schwartz, C., Vila, J., Burny, A., Clumeck, N., Moutschen, M., De Wit, S., Peterlin, M., Rouzioux, C., Rohr, O., & Van Lint, C. (2015).(O. Rohr and C. Van Lint are co-last authors) "An In-Depth Comparison of Latency-Reversing Agent Combinations in Various in vitro and ex vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression." PLoS pathogens, 11(7), e1005063..

  • Sauter, D., Hotter, D., Van Driessche, B., Stürzel, C. M., Kluge, S. F., Wildum, S., Yu, H., Baumann, B., Wirth, T., Plantier, J.-C., Leoz, M., Hahn, B. H., Van Lint, C., & Kirchhoff, F. (2015). "Differential Regulation of NF-kB-Mediated Proviral and Antiviral Host Gene Expression by Primate Lentiviral Nef and Vpu Proteins." Cell reports, 10, 586-599..

2014

  • Colin, L., Verdin, E., & Van Lint, C. (2014). "HIV-1 chromatin, transcription, and the regulatory protein tat." Methods in molecular biology, 1087, 85-101..

  • Hanotel, J., Bessodes, N., Thelie, A., Hedderich, M., Parain, K., Van Driessche, B., Brandão De Oliveira, K., Kricha, S., Jorgensen, M. C., Grapin-Botton, A., Serup, P., Van Lint, C., Perron, M., Pieler, T., Henningfeld, K. A., & Bellefroid, E. (2014). "The Prdm13 histone methyltransferase encoding gene is a Ptf1a-Rbpj downstream target that suppresses glutamatergic and promotes GABAergic neuronal fate in the dorsal neural tube." Developmental biology, 386(2), 340-357..

  • Eilebrecht, S., Le Douce, V., Roclet, R., Targat, B., Hallay, H., Van Driessche, B. , Schwartz, C., Robette, G., Van Lint, C., Rohr, O., & Benecke, A. (2014). "HMGA1 recruits CTIP2-repressed P-TEFb to the HIV-1 and cellular target promoters." Nucleic acids research, 42(8), 4962-4971..

2013

  • Van Lint, C., Bouchat, S., & Marcello, A. (2013). "HIV-1 transcription and latency: an update." Retrovirology, 10, 67..

  • Cherrier, T., Le Douce, V., Eilebrecht, S., Riclet, R., Marban, C., Dequiedt, F., Goumon, Y., Paillart, J.-C., Mericskay, M., Parlakian, A., Bausero, P., Abbas, W., Herbein, G., Kurdistani, S., Grana, X., Van Driessche, B., Candolfi, E., Schwartz, C., Benecke, A., Van Lint, C., & Rohr, O. (2013). (C. Van Lint and O. Rohr are co-last authors). "CTIP2 is a negative regulator of P-TEFb" Proceedings of the National Academy of Sciences of the United States of America, 110(31) .

2012

  • Simonis, N., Rual, J.-F., Lemmens, I., Boxus, M., Hirozane-Kishikawa, T., Gatot, J.-S., Dricot, A., Hao, T., Vertommen, D., Legros, S., Daakour, S., Klitgord, N., Martin, M., Willaert, J.-F., Dequiedt, F., Navratil, V., Cusick, M. E., Burny, A., Van Lint, C., Hill, D. E., Tavernier, J., Kettmann, R., Vidal, M., & Twizere, J.-C. (2012). "Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses." Retrovirology, 9, 26..

  • The International AIDS Society Scientific Working Group on HIV Cure,Deeks, S., Autran, B., Berkhout, B., Benkirane, M., Cairns, S., Chomont, N., Chun, T.-W., Churchill, M., Mascio, M. D., Katlama, C., Lafeuillade, A., Landay, A., Lederman, M., Lewin, S. R., Maldarelli, F., Margolis, D., Markowitz, M., Martinez-Picado, J., Mullins, J. I., Mellors, J., Moreno, S., O'Doherty, U., Palmer, S., Penicaud, M.-C., Peterlin, M., Poli, G., Routy, J.-P., Rouzioux, C., Silvestri, G., Stevenson, M., Telenti, A., Van Lint, C., Verdin, E., Woolfrey, A., Zaia, J., & Barré-Sinoussi, F. (2012). "Towards an HIV cure: a global scientific strategy." Nature reviews. Immunology, 12(8), 607-614..

  • Bouchat, S., Gatot, J.-S., Kabeya, K., Cardona, C., Colin, L., Herbein, G., De Wit, S., Clumeck, N., Lambotte, O., Rouzioux, C., Rohr, O., & Van Lint, C. (2012). "Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients." AIDS, 26(12), 1473-1482..

  • Le Douce, V., Colin, L., Redel, L., Cherrier, T., Herbein, G., Aunis, D., Rohr, O., Van Lint, C., & Schwartz, C. (2012). (O.Rohr, C. Van Lint and C. Schwartz are co-corresponding authors) "LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing" Nucleic acids research, 40, 1904-1915..

2011

  • Colin, L., Vandenhoudt, N., De Walque, S., Van Driessche, B., Bergamaschi, A., Martinelli, V., Cherrier, T., Vanhulle, C., Guiguen, A., David, A., Burny, A., Herbein, G., Pancino, G., Rohr, O., & Van Lint, C. (2011). "The AP-1 binding sites located in the pol gene intragenic regulatory region of HIV-1 are important for viral replication." PloS one, 6(4), e19084..

  • Vandurm, P., Guiguen, A., Cauvin, C., Georges, B., Le Van, K., Michaux, C., Cardona, C., Mbemba, G., Mouscadet, J.-F., Hevesi, L., Van Lint, C., & Wouters, J. (2011). "Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition." European journal of medicinal chemistry, 46(5), 1749-1756..

Lens, Z., Dewitte, F., Van Lint, C., De Launoit, Y., Villeret, V., & Verger, A. (2011). "Purification of SUMO-1 modified I#B# and complex formation with NF-#B." *Protein expression and purification Volume 80, Issue 2, 2011, Pages 211-216,.

  • Legros, S., Boxus, M., Gatot, J.-S., Van Lint, C., Kruys, V., Kettmann, R., Twizere, J.-C., & Dequiedt, F. (2011). "The HTLV-1 Tax protein inhibits formation of stress granules by interacting with histone deacetylase 6." Oncogene, 30(38), 4050-4062.

  • Colin, L., Dekoninck, A., Reichert, M., Calao, M., Merimi, M., Van Den Broeke, A., Vierendeel, V., Cleuter, Y., Burny, A., Rohr, O., & Van Lint, C. (2011). "Chromatin disruption in the promoter of Bovine Leukemia Virus during transcriptional activation." Nucleic acids research, 39, 9559-9573..

2010

  • Lens, Z., Dewitte, F., Monte, D., Baert, J.-L., Bompard, C., Sénéchal, M., Van Lint, C., De Launoit, Y., Villeret, V., & Verger, A. (2010). "Solution structure of the N-terminal transactivation domain of ERM modified by SUMO-1." Biochemical and biophysical research communications, 399(1), 104-110..

  • Trono, D., Van Lint, C., Rouzioux, C., Verdin, E., Barré-Sinoussi, F., Chun, T.-W., & Chomont, N. (2010). "HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals." Science, 329(5988), 174-180..

  • Redel, L., Le Douce, V., Cherrier, T., Marban, C., Janossy, A., Aunis, D., Van Lint,C., Rohr, O., & Schwartz, C. (2010). "HIV-1 regulation of latency in the monocytemacrophage lineage and in CD4+ T lymphocytes." Journal of leukocyte biology, 87, 575-588..

  • Pierard, V., Guiguen, A., Colin, L., Wijmeersch, G., Vanhulle, C., Van Driessche, B., Dekoninck, A., Blazkova, J., Cardona, C., Merimi, M., Vierendeel, V., Calomme, C., Nguyen, T. L.-A., Nuttinck, M., Twizere, J.-C., Kettmann, R., Portetelle, D., Burny, A., Hirsch, I., Rohr, O., & Van Lint, C. (2010). "DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: Potential involvement of direct inhibition of CREB/CREM/ATF transcription factor binding." The Journal of biological chemistry. Volume 285, Issue 25, 2010, Pages 19434-19449 .

2009

  • Reuse, S., Calao, M., Kabeya, K., Guiguen, A., Gatot, J.-S., Quivy, V., Vanhulle, C., Lamine, A., Vaira, D., Demonte, D., Martinelli, V., Veithen, E., Cherrier, T., Avettand, V., Poutrel, S., Piette, J., De Launoit, Y., Moutschen, M., Burny, A., Rouzioux, C., De Wit, S., Herbein, G., Rohr, O., Collette, Y., Lambotte, O., Clumeck, N., & Van Lint, C. (2009). "Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection." PloS one, 4(6), e6093..

  • Blazkova, J., Trejbalova, K., Gondois-Rey, F., Halfon, P., Philibert, P., Guiguen, A., Verdin, E., Olive, D., Van Lint, C., Hejnar, J., & Hirsch, I. (2009). "CpG methylation controls reactivation of HIV from latency." PLoS pathogens, 5(8), e1000554..

  • Ndlovu, M. N., Van Lint, C., Van Wesemael, K., Callebert, P., Chalbos, D., Haegeman, G., & Vanden Berghe, W. (2009). "Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells." Molecular and cellular biology, 29(20), 5488-5504..

  • Vire, B., De Walque, S., Restouin, A., Olive, D., Van Lint, C., & Collette, Y. (2009). "Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions." PloS one, 4(9), e7085..

  • Le Van, K., Cauvin, C., De Walque, S., Georges, B., Boland, S., Martinelli, V., Demonte, D., Durant, F., Hevesi, L., & Van Lint, C. (2009). "New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors." Journal of medicinal chemistry, 52(12), 3636-3643.

  • Cherrier, T., Suzanne, S., Redel, L., Calao, M., Marban, C., Samah, B., Mukerjee, R., Schwartz, C., Gras, G., Sawaya, B. E., Zeichner, S. L., Aunis, D., Van Lint, C., & Rohr,O. (2009). "p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1." Oncogene, 28(38), 3380-3389..

  • Vandurm, P., Cauvin, C., Guiguen, A., Georges, B., Le Van, K., Martinelli, V., Cardona, C., Mbemba, G., Mouscadet, J.-F., Hevesi, L., Van Lint, C., & Wouters, J. (2009). "Structural and theoretical studies of [6-bromo-1-(4-fluorophenylmethyl)-4(1H)-quinolinon-3-yl)]-4-hydroxy-2-oxo-3-butenoïc acid as HIV-1 integrase inhibitor." Bioorganic & medicinal chemistry letters, 19(16), 4806-4809..

  • Colin, L., & Van Lint, C. (2009). "Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies." Retrovirology, 6, 111 (2009).

2008

  • Mahlknecht, U., Dichamp, I., Varin, A., Van Lint, C., & Herbein, G. (2008). "NF-kappaB-dependent control of HIV-1 transcription by the second coding exon of Tat in T cells." Journal of leukocyte biology, 83(3), 718-727..

  • Calao, M., Burny, A., Quivy, V., Dekoninck, A., & Van Lint, C. (2008). "A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code." Trends in biochemical sciences, 33(7), 339-349..

2007

  • Twizere, J.-C., Springael, J.-Y., Boxus, M., Burny, A., Dequiedt, F., Dewulf, J.-F., Duchateau, J., Portetelle, D., Urbain, P., Van Lint, C., Green, P. L., Mahieux, R., Parmentier, M., Willems, L., & Kettmann, R. (2007). "Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling." Blood, 109(3), 1051-1060..

  • Sharma, A., Awasthi, S., Harrod, C. K., Matlock, E. F., Khan, S., Xu, L., Chan, S., Yang, H., Thammavaram, C. K., Rasor, R. A., Burns, D. K., Skiest, D. J., Van Lint, C., Girard, A.-M., McGee, M., Monnat, R. J., & Harrod, R. (2007). "The Werner syndrome helicase is a cofactor for HIV-1 long terminal repeat transactivation and retroviral replication." The Journal of biological chemistry, 282(16), 12048-12057..

  • Horion, J., Gloire, G., El Mjiyad, N., Quivy, V., Vermeulen, L., Vanden Berghe, W., Haegeman, G., Van Lint, C., Piette, J., & Habraken, Y. (2007). "Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha." The Journal of biological chemistry, 282(21), 15383-15393.

  • Marban, C., Suzanne, S., Dequiedt, F., De Walque, S., Redel, L., Van Lint, C.,Aunis, D., & Rohr, O. (2007). "Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing." EMBO journal, 26(2), 412-423..

  • Vandergeeten, C., Quivy, V., Moutschen, M., Van Lint, C., Piette, J., & Legrand-Poels, S. (2007). "HIV-1 protease inhibitors do not interfere with provirus transcription and host cell apoptosis induced by combined treatment TNF-alpha + TSA." Biochemical pharmacology, 73(11), 1738-1748..

  • Nguyen, T. L.-A., De Walque, S., Veithen, E., Dekoninck, A., Martinelli, V., De Launoit, Y., Burny, A., Harrod, R., & Van Lint, C. (2007). "Transcriptional regulation of the bovine leukemia virus promoter by the cyclic AMP-response element modulator tau isoform." The Journal of biological chemistry, 282(29), 20854-20867.

  • Quivy, V., De Walque, S., & Van Lint, C. (2007). "Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies." Sub-cellular biochemistry, 41, 371-396..

2006

  • Castellano, R., Vire, B., Pion, M., Quivy, V., Olive, D., Hirsch, I., Van Lint, C., & Collette, Y. (2006). "Active transcription of the human FASL/CD95L/TNFSF6 promoter region in T lymphocytes involves chromatin remodeling: role of DNA methylation and protein acetylation suggest distinct mechanisms of transcriptional repression." The Journal of biological chemistry, 281(21), 14719-14728.

  • Mauen, S., Huvent, I., Raussens, V., Demonte, D., Baert, J.-L., Tricot, C., Ruysschaert, J. M., Van Lint, C., Moguilevsky, N., & De Launoit, Y. (2006). "Expression, purification, and structural prediction of the Ets transcription factor ERM." Biochimica et biophysica acta, 1760(8), 1192-1201.

  • Wong, K., Sharma, A., Awasthi, S., Matlock, E. F., Rogers, L., Van Lint, C., Skiest, D. J., Burns, D. K., & Harrod, R. (2005). "HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB." The Journal of biological chemistry, 280(10), 9390-9399.

2005

  • T'Sas, F., Brenner, C., Mauen, S., Putmans, P., Monte, D., Van Lint, C., Moser, M., Baert, J.-L., & De Launoit, Y. (2005). "Expression of the Ets transcription factor Erm is regulated through a conventional PKC signaling pathway in the Molt4 lymphoblastic cell line." FEBS letters, 579(1), 66-70..

  • Marban, C., Redel, L., Suzanne, S., Van Lint, C., Lecestre, D., Chasserot-Golaz, S., Leid, M., Aunis, D., Schaeffer, E., & Rohr, O. (2005). "COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells." Nucleic acids research, 33(7), 2318-2331..

  • Kim, Y.-S., Kim, J.-M., Jung, D.-L., Kang, J.-E., Lee, S., Kim, J. S., Seol, W., Shin, H.-C., Kwon, H. S., Van Lint, C., Hernandez, N., & Hur, M.-W. (2005). "Artificial zinc finger fusions targeting Sp1-binding sites and the trans-activator-responsive element potently repress transcription and replication of HIV-1." The Journal of biological chemistry, 280(22),21545-21552..

  • Goffin, V., Demonte, D., Vanhulle, C., De Walque, S., De Launoit, Y., Burny, A., Collette, Y., & Van Lint, C. (2005). "Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity." Nucleic acids research, 33(13), 4285-4310.

  • Desfosses, Y., Solis, M., Sun, Q., Grandvaux, N., Van Lint, C., Burny, A., Gatignol, A., Wainberg, M. A., Lin, R., & Hiscott, J. (2005). "Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins." Journal of virology, 79(14),9180-9191..

  • Varin, A., Decrion, A.-Z., Sabbah, E., Quivy, V., Sire, J., Van Lint, C., Roques, B. P., Aggarwal, B. B., & Herbein, G. (2005). "Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages." The Journal of biological chemistry, 280(52), 42557-42567..

2004

  • Van Lint, C., Quivy, V., Demonte, D., Chariot, A., Vanhulle, C., De Walque, S., Gaudray, G., Veithen, E., Bours, V., Piette, J., & Burny, A. (2004). "Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies." Bulletin et mémoires de l'Académie royale de médecine de Belgique, 159(Pt 2), 176-189.

  • Van Lint, C. (2004). "Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter." AIDS reviews, 6(1), 61-62..

  • Wong, K., Zhang, J., Awasthi, S., Sharma, A., Rogers, L., Matlock, E. F., Van Lint, C., Karpova, T., McNally, J., & Harrod, R. (2004). "Nerve growth factor receptor signaling induces histone acetyltransferase domain-dependent nuclear translocation of p300/CREBbinding protein-associated factor and hGCN5 acetyltransferases." The Journal of biological chemistry, 279(53), 55667-55674..

  • Nguyen, T. L.-A., Calomme, C., Wijmeersch, G., Nizet, S., Veithen, E., Portetelle, D., De Launoit, Y., Burny, A., & Van Lint, C. (2004). "Deacetylase inhibitors and the viral transactivator TaxBLV synergistically activate bovine leukemia virus gene expression via a cAMP-responsive element- and cAMP-responsive element-binding protein-dependent mechanism." The Journal of biological chemistry, 279(33), 35025-35036..

  • Goriely, S., Van Lint, C., Dadkhah, R., Libin, M., De Wit, D., Demonte, D., Willems, F., & Goldman, M. (2004). "A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells." The Journal of experimental medicine, 199(7), 1011-1016..

  • Quivy, V., Calomme, C., Dekoninck, A., Demonte, D., Bex, F., Lamsoul, I., Vanhulle, C., Burny, A., & Van Lint, C. (2004). "Gene activation and gene silencing: a subtle equilibrium." Cloning and stem cells, 6(2), 140-149..

  • Demonte, D., Quivy, V., Colette, Y., & Van Lint, C. (2004). "Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies." Biochemical pharmacology, 68(6), 1231-1238..

  • Quivy, V., & Van Lint, C. (2004). "Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation." Biochemical pharmacology, 68(6), 1221-1229..

  • Calomme, C., Dekoninck, A., Nizet, S., Adam, E., Nguyen, T. L.-A., Van Den Broeke, A., Willems, L., Kettmann, R., Burny, A., & Van Lint, C. (2004). "Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency." Journal of virology, 78(24), 13848-13864..

2003

  • Varin, A., Manna, S. K., Quivy, V., Decrion, A.-Z., Van Lint, C., Herbein, G., & Aggarwal, B. B. (2003). "Exogenous Nef protein activates NF-kappa B, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells." Role in AIDS pathogenesis. The Journal of biological chemistry, 278(4), 2219-2227..

  • Maurer, P., T'Sas, F., Coutte, L., Callens, N., Brenner, C., Van Lint, C., De Launoit, Y., & Baert, J.-L. (2003). "FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain." Oncogene, 22(21), 3319-3329 .

  • Harrod, R., Nacsa, J., Van Lint, C., Hansen, J., Karpova, T., McNally, J., & Franchini, G. (2003). "Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription." The Journal of biological chemistry, 278(14), 12310-12318.

  • Dekoninck, A., Calomme, C., Nizet, S., De Launoit, Y., Burny, A., Ghysdael, J., & Van Lint, C. (2003). "Identification and characterization of a PU.1/Spi-B binding site in the bovine leukemia virus long terminal repeat." Oncogene, 22(19), 2882-2896..

  • Viatour, P., Legrand-Poels, S., Van Lint, C., Warnier, M., Merville, M.-P., Gielen, J., Piette, J., Bours, V., & Chariot, A. (2003). "Cytoplasmic IkappaBalpha increases NFkappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3." The Journal of biological chemistry, 278(47), 46541-46548..

  • Adam, E., Quivy, V., Bex, F., Chariot, A., Collette, Y., Vanhulle, C., Schoonbroodt, S., Goffin, V., Nguyen, T. L.-A., Gloire, G., Carrard, G., Friguet, B., De Launoit, Y., Burny, A., Bours, V., Piette, J., & Van Lint, C. (2003). "Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha." Molecular and cellular biology, 23(17), 6200-6209.

  • Callens, N., Baert, J.-L., Sunesen, M., Van Lint, C., & De Launoit, Y. (2003). "Transcriptional regulation of the murine brca2 gene by CREB/ATF transcription factors." Biochemical and biophysical research communications, 312(3), 702-707..

  • Pouillon, V., Hascakova-Bartova, R., Pajak, B., Adam, E., Bex, F., Dewaste, V., Van Lint, C., Leo, O., Erneux, C., & Schurmans, S. (2003). "Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte development." Nature immunology, 4(11), 1136-1143..

  • Goriely, S., Demonte, D., Nizet, S., De Wit, D., Willems, F., Goldman, M., & Van Lint,C. (2003). "Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1-binding sites." Blood,101(12), 4894-4902..

  • Szynal, M., Cleuter, Y., Beskorwayne, T., Bagnis, C., Van Lint, C., Kerkhofs, P., Burny, A., Martiat, P., Griebel, P., & Van Den Broeke, A. (2003). "Disruption of B-cell homeostatic control mediated by the BLV-Tax oncoprotein: association with the upregulation of Bcl-2 and signaling through NF-kappaB." Oncogene, 22(29), 4531-4542.

2002

  • Callens, N., Dumont, M., Begue, A., Van Lint, C., Baert, J.-L., Simard, J., & De Launoit, Y. (2002). "Genomic organization and expression of the mouse Brca2 gene." Mammalian genome, 13(7), 352-358..

  • Demonte, D., Van Lint, C., & Burny, A. (2002). "La thérapie génique." Revue Médicale de Bruxelles, 23(4), A331-A334..

  • Merezak, C., Reichert, M., Van Lint, C., Kerkhofs, P., Portetelle, D., Willems, L., & Kettmann, R. (2002). "Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo." Journal of virology, 76(10), 5034-5042..

  • Quivy, V., Adam, E., Collette, Y., Demonte, D., Chariot, A., Vanhulle, C., Berkhout, B., Castellano, R., De Launoit, Y., Burny, A., Piette, J., Bours, V., & Van Lint, C. (2002). "Synergistic activation of human immunodeficiency virus type 1 promoter activity by NFkappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies." Journal of virology, 76(21), 11091-11103..

  • Iordanskiy, S., Iordanskaya, T., Quivy, V., Van Lint, C., & Bukrinsky, M. (2002). "Boligomer of pertussis toxin inhibits HIV-1 LTR-driven transcription through suppression of NF-kappaB p65 subunit activity." Virology, 302(1), 195-206..

  • Gatot, J.-S., Callebaut, I., Van Lint, C., Demonte, D., Kerkhofs, P., Portetelle, D., Burny, A., Willems, L., & Kettmann, R. (2002). "Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo." Journal of virology, 76(16), 7956-7967..

  • Castellano, R., Van Lint, C., Peri, V., Veithen, E., Morel, Y., Costello, R., Olive, D., & Collette, Y. (2002). "Mechanisms regulating expression of the tumor necrosis factor-related light gene. Role of calcium-signaling pathway in the transcriptional control." The Journal of biological chemistry, 277(45), 42841-42851.

  • Calomme, C., Nguyen, T. L.-A., De Launoit, Y., Kiermer, V., Droogmans, L., Burny, A., & Van Lint, C. (2002). "Upstream stimulatory factors binding to an E box motif in the R region of the bovine leukemia virus long terminal repeat stimulates viral gene expression." The Journal of biological chemistry, 277(11), 8775-8789..

  • Quivy, V., & Van Lint, C. (2002). "Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system." Biochemical pharmacology, 64(5-6), 925-934.

2001

  • Burny, A., Demonte, D., & Van Lint, C. (2001). "Les gènes: moteurs de la vie et de la maladie." Bulletin et mémoires de l'Académie royale de médecine de Belgique, 156(10-12), 533-544..

  • Bentires-Alj, M., Dejardin, E., Viatour, P., Van Lint, C., Froesch, B., Reed, J. C., Merville, M.-P., & Bours, V. (2001). "Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines." Oncogene, 20(22), 2805-2813..

  • Merezak, C., Pierreux, C., Adam, E., Lemaigre, F., Rousseau, G., Calomme, C., Van Lint, C., Christophe, D., Kerkhofs, P., Burny, A., Kettmann, R., & Willems, L. (2001). "Suboptimal enhancer sequences are required for efficient Bovine Leukemia Virus propagation in vivo: implications for viral latency." Journal of Virology, 75(15), 6977-6988.

2000

  • Van Lint, C. (2000). "Role of chromatin in HIV-1 transcriptional regulation." Advances in pharmacology, 48, 121-160..

1999

  • Critchfield, J. W., Ho, O., Roberts, M., Van Lint, C., Verdin, E., & Butera, S. T. (1999). "Isoquinolinesulphonamide derivatives inhibit transcriptional elongation of human immunodeficiency virus type 1 RNA in a promyelocytic model of latency." Antiviral chemistry & chemotherapy, 10(5), 275-284..

  • Chariot, A., Van Lint, C., Chapelier, M., Gielen, J., Merville, M.-P., & Bours, V. (1999). "CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein." Oncogene, 18(27), 4007-4014..

  • Kiernan, R. E., Vanhulle, C., Schiltz, L., Adam, E., Xiao, H., Maudoux, F., Calomme, C., Burny, A., Nakatani, Y., Jeang, K. T., Benkirane, M. M., & Van Lint, C. (1999). "HIV-1 tat transcriptional activity is regulated by acetylation." EMBO journal, 18(21), 6106-6118..

1998

  • Emiliani, S., Fischle, W., Van Lint, C., Al-Abed, Y., & Verdin, E. (1998). "Characterization of a human RPD3 ortholog, HDAC3." Proceedings of the National Academy of Sciences of the United States of America, 95(6), 2795-2800.

  • Kiermer, V., Van Lint, C., Briclet, D., Vanhulle, C., Kettmann, R., Verdin, E., Burny, A., & Droogmans, L. (1998). "An interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates Tax-independent gene expression." Journal of virology, 72(7), 5526-5534..

  • Herbein, G., Van Lint, C., Lovett, J., & Verdin, E. (1998). "Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes." Journal of virology, 72(1), 660-670.

  • Emiliani, S., Fischle, W., Ott, M., Van Lint, C., Amella, C. A., & Verdin, E. (1998). "Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line." Journal of virology, 72(2), 1666-1670.

1997

  • Ott, M., Emiliani, S., Van Lint, C., Herbein, G., Lovett, J., Chirmule, N., McCloskey, T., Pahwa, S., & Verdin, E. (1997). "Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway." Science, 275(5305), 1481-1485..

  • Van Lint, C., Amella, C. A., Emiliani, S., John, M., Jie, T., & Verdin, E. (1997). "Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity." Journal of virology, 71(8), 6113-6127..

1996

  • Van Lint, C., Emiliani, S., Ott, M., & Verdin, E. (1996). "Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation." EMBO journal, 15(5), 1112-1120..

  • Van Lint, C., Emiliani, S., & Verdin, E. (1996). "The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation." Gene expression, 5(4-5), 245-253..

  • Emiliani, S., Van Lint, C., Fischle, W., Paras, P., Ott, M., Brady, J., & Verdin, E. (1996). "A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. " Proceedings of the National Academy of Sciences of the United States of America, 93(13), 6377-6381..

1995

  • Verdin, E., & Van Lint, C. (1995). "Internal transcriptional regulatory elements in HIV-1 and other retroviruses." Cellular and molecular biology, 41(3), 365-369.

1994

  • Van Lint, C., Ghysdael, J., Paras, P., Burny, A., & Verdin, E. (1994). "A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1." Journal of virology, 68(4), 2632-2648.

1993

  • Verdin, E., Paraskevas, P., & Van Lint, C. (1993). "Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation." EMBO journal, 12(8), 3249-3259..

1991

  • Van Lint, C., Burny, A., & Verdin, E. (1991). "The intragenic enhancer of human immunodeficiency virus type 1 contains functional AP-1 binding sites." Journal of virology, 65(12), 7066-7072..